John Overdeck’s Bristol-Myers Squibb BMY Stock Holding History

John Overdeck’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-18,400	Closed	-$1.12M	–	5074
2026 Q1	$1.12M	Buy	+18,400	New	+$1.07M	﹤0.01%	3180
2022 Q1	–	Sell	-212,400	Closed	-$13.2M	–	2818
2021 Q4	$13.2M	Buy	212,400 +201,100	+1,780%	+$11.8M	0.03%	654
2021 Q3	$669K	Sell	11,300 -105,200	-90%	-$6.93M	﹤0.01%	3000
2021 Q2	$7.79M	Sell	116,500 -279,000	-71%	-$18.2M	0.02%	950
2021 Q1	$25M	Buy	395,500 +370,800	+1,501%	+$23.1M	0.07%	356
2020 Q4	$1.53M	Sell	24,700 -131,600	-84%	-$8.09M	﹤0.01%	1679
2020 Q3	$9.42M	Buy	156,300 +152,200	+3,712%	+$9.16M	0.03%	523
2020 Q2	$241K	Sell	4,100 -302,800	-99%	-$18.1M	﹤0.01%	2517
2020 Q1	$17.1M	Buy	306,900 +192,900	+169%	+$11.8M	0.14%	151
2019 Q4	$7.32M	Sell	114,000 -18,500	-14%	-$1.06M	0.02%	754
2019 Q3	$6.72M	Buy	132,500 +31,600	+31%	+$1.49M	0.02%	721
2019 Q2	$4.58M	Buy	+100,900	New	+$4.7M	0.02%	945
2018 Q4	–	Sell	-54,800	Closed	-$3.4M	–	2998
2018 Q3	$3.4M	Sell	54,800 -67,600	-55%	-$4.01M	0.01%	1134
2018 Q2	$6.77M	Buy	122,400 +45,500	+59%	+$2.46M	0.02%	875
2018 Q1	$4.86M	Buy	+76,900	New	+$4.95M	0.02%	963
2017 Q2	–	Sell	-24,800	Closed	-$1.35M	–	2963
2017 Q1	$1.35M	Sell	24,800 -42,300	-63%	-$2.32M	﹤0.01%	1719
2016 Q4	$3.92M	Buy	67,100 +16,700	+33%	+$913K	0.02%	981
2016 Q3	$2.72M	Sell	50,400 -43,600	-46%	-$2.8M	0.01%	1248
2016 Q2	$6.91M	Buy	94,000 +18,000	+24%	+$1.27M	0.03%	630
2016 Q1	$4.86M	Sell	76,000 -88,000	-54%	-$5.55M	0.02%	726
2015 Q4	$11.3M	Buy	+164,000	New	+$10.8M	0.05%	380

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

John Overdeck's BMY Position: Q2 2026 in Review

John Overdeck reduced its Bristol-Myers Squibb (BMY) stake by 13% in Q2 2026, selling an estimated $83.2M and leaving 10,085,383 shares worth $581M. The position accounts for 0.42% of the portfolio, ranked #36.

John Overdeck first reported a position in BMY in Q3 2013 and has held it in 46 quarters since. The position peaked at $700M in Q1 2026. 2,506 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

John Overdeck held 10,085,383 shares of Bristol-Myers Squibb worth $581M as of Q2 2026.
John Overdeck sold 1,449,723 Bristol-Myers Squibb shares in Q2 2026, an estimated $83.2M.
Bristol-Myers Squibb made up 0.42% of John Overdeck's portfolio in Q2 2026, its #36 holding.
John Overdeck first reported a position in Bristol-Myers Squibb in Q3 2013 and has held it in 46 quarters since.
John Overdeck's Bristol-Myers Squibb position peaked at $700M in Q1 2026.
2,506 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.